1. Home
  2. NCTY vs CYPH Comparison

NCTY vs CYPH Comparison

Compare NCTY & CYPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The9 Limited American Depository Shares

NCTY

The9 Limited American Depository Shares

HOLD

Current Price

$4.70

Market Cap

66.0M

ML Signal

HOLD

Logo Cypherpunk Technologies Inc.

CYPH

Cypherpunk Technologies Inc.

HOLD

Current Price

$1.92

Market Cap

73.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NCTY
CYPH
Founded
1999
2011
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.0M
73.3M
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
NCTY
CYPH
Price
$4.70
$1.92
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
279.4K
4.8M
Earning Date
03-27-2015
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
103.87
EPS
N/A
N/A
Revenue
N/A
$1,500,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.14
$0.49
52 Week High
$11.60
$3.70

Technical Indicators

Market Signals
Indicator
NCTY
CYPH
Relative Strength Index (RSI) 50.55 89.91
Support Level $3.27 $0.56
Resistance Level $5.62 N/A
Average True Range (ATR) 0.76 0.19
MACD 0.03 0.12
Stochastic Oscillator 28.97 90.90

Price Performance

Historical Comparison
NCTY
CYPH

About NCTY The9 Limited American Depository Shares

The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Online game services, out of which Crypto mining business derives maximum revenue.

About CYPH Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

Share on Social Networks: